Last edition
News about "Kai Beckmann "
Merck KGaA Acquires Bio-Techne to Expand Life Sciences Business
Merck KGaA will acquire Bio-Techne in a USD 11.3 billion deal, strengthening its leadership in life sciences and expanding capabilities across high-growth markets.
Kai Beckmann | 26/06/2026 | By News Bureau
Kai Beckmann to Lead Merck as CEO and Executive Board Chair
The Board of Partners of E. Merck KG appointed Kai Beckmann as future Chairman of the Executive Board and CEO of Merck. Belén Garijo’s tenure to be completed as planned by end of April 2026.
Kai Beckmann | 30/09/2025 | By Dineshwori | 277
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy